Cargando…
Treatment of Hyperammonemia Syndrome in Lung Transplant Recipients
Hyperammonemia syndrome is a complication that has been reported to occur in 1–4% of lung transplant patients with mortality rates as high as 60–80%, making detection and management crucial components of post-transplant care. Patients are treated with a multimodal strategy that may include renal rep...
Autores principales: | Yun, Sarah, Scalia, Ciana, Farghaly, Sara |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10672283/ https://www.ncbi.nlm.nih.gov/pubmed/38002590 http://dx.doi.org/10.3390/jcm12226975 |
Ejemplares similares
-
Hyperammonemia Post Lung Transplantation: A Review
por: Leger, Robert F, et al.
Publicado: (2020) -
The hyperornithinemia–hyperammonemia-homocitrullinuria syndrome
por: Martinelli, Diego, et al.
Publicado: (2015) -
Two Cases of Fatal Hyperammonemia Syndrome due to Mycoplasma hominis and Ureaplasma urealyticum in Immunocompromised Patients Outside Lung Transplant Recipients
por: Nowbakht, Cima, et al.
Publicado: (2019) -
Hyperammonemia by Ureaplasma urealyticum Pneumonia after Lung Transplantation
por: Paparoupa, Maria, et al.
Publicado: (2020) -
Mycoplasma and Ureaplasma Donor-Derived Infection and Hyperammonemia Syndrome in 4 Solid Organ Transplant Recipients From a Single Donor
por: Wigston, Charlotte, et al.
Publicado: (2023)